Chemistry of Natural Compounds

, Volume 8, Issue 6, pp 763–768 | Cite as

Characteristics of the cholinesterase of the venom of the central Asian cobra

  • V. M. Sorokin
  • Z. Nigmatov
  • L. Ya. Yukel'son


1. By rechromatography on sulfoethyl-Sephadex C-50, an electrophoretically homogeneous preparation of cholinesterase has been obtained from the venom ofNaja oxiana Eichwald.

2. The activity of the cholinesterase isolated depends on the concentration of the enzyme and the time and temperature of incubation, and also on the pH. The following must be considered the optimum conditions: time of incubation of the enzyme with the substrate 20–30 min, pH 8.0–8.5, temperature 37–38°C.

3. Diisopropyl phosphorofluoridate (DIPF) in a concentration of 2 µM completely suppresses the activity of the cobra venom cholinesterase.

4. The venom cholinesterase hydrolyzes acetylcholine chloride and acetylthiocholine bromide but has no effect on butyrylthiocholine bromide, in which respect it resembles the true cholinesterases.

5. Preparations of cobra venom cholinesterase do not possess a lethal action and do not potentiate the activity of the neurotoxins of the same venom.


Acetylcholine Cholinesterase Cholinesterase Activity Thiocholine Cobra Venom 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature cited

  1. 1.
    N. K. Iyengar, N. B. Sehra, B. Mukerji, and R. N. Chopra, Current Sci.,7, 51 (1938).Google Scholar
  2. 2.
    E. A. Zeller, Experientia,3, 375 (1947).CrossRefGoogle Scholar
  3. 3.
    L. Ya. Yukel'son and M. Malikov, in: Questions of Medicinal Chemistry and the Action of Physiologically Active Substances [in Russian], Tashkent (1970), p. 76.Google Scholar
  4. 4.
    E. A. Zeller, Advan. Enzymol.,8, 459 (1948).Google Scholar
  5. 5.
    C.-Y. Lee, C.-C. Chang, and K. Kamijo, Venoms (First International Conference, December 27–30, 1954, Berkeley, Calif.), Washington (1956), p. 197.Google Scholar
  6. 6.
    D. K. Chowdhury, Ann. Biochem. Exp. Med.,4, 77 (1944).Google Scholar
  7. 7.
    Ya. Kh. Turakulov, D. N. Sakhiborv, V. M. Sorokin, and L. Ya. Yukel'son, Biokhimiya,34, 1119 (1969).Google Scholar
  8. 8.
    V. M. Sorokin, Z. Nigmatov, and L. Ya. Yukel'son, Biokhimiya,37, 1 (1972).Google Scholar
  9. 9.
    A. N. Panyukov, Vopr. Med. Khim.,12, 88 (1966).Google Scholar
  10. 10.
    B. J. Davis and L. Ornstein, Ann. New York Acad. Sci.,121, 321, 404 (1964).Google Scholar
  11. 11.
    M. L. Belen'kii, Elements of the Quantitative Evaluation of Pharmaceutical Effects [in Russian], Leningrad (1963).Google Scholar
  12. 12.
    J. P. Changeux, T. R. Podleski, and J. C. Meunier, J. Gen. Physiol.,54, 225 (1969).CrossRefGoogle Scholar
  13. 13.
    V. L. Kretovich, Introduction to Enzymology [in Russian], Moscow (1967).Google Scholar
  14. 14.
    E. Heilbron, Acta Chem. Scand.,8, 1368 (1954).CrossRefGoogle Scholar
  15. 15.
    D. K. Chowdhury, Ann. Biochem. Exp. Med.,9, 85 (1949).Google Scholar
  16. 16.
    W. Björk, Biochem. Biophys. Acta,49, 195 (1961).CrossRefGoogle Scholar
  17. 17.
    D. K. Chowdhury, Ann. Biochem. Exp. Med.,9, 73 (1949).Google Scholar
  18. 18.
    J. L. Webb, Enzyme and Metabolic Inhibitors, Academic Press (1963–1966).Google Scholar
  19. 19.
    S. N. Golikov and V. I. Rozengart, Cholinesterases and Anticholinesterase Agents [in Russian], Leningrad (1964).Google Scholar
  20. 20.
    C.-C. Yang, W.-C. Chin, and K.-C. Kao, J. Biochem. (Japan),48, 706 (1960).CrossRefGoogle Scholar
  21. 21.
    Ya. Kh. Turakulov, V. M. Sorokin, S. A. Nishankhodzhaeva, and L. Ya. Yukel'son, Biokhimiya,35, 1282 (1971).Google Scholar

Copyright information

© Consultants Bureau 1974

Authors and Affiliations

  • V. M. Sorokin
  • Z. Nigmatov
  • L. Ya. Yukel'son

There are no affiliations available

Personalised recommendations